Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, operating through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and other subsidiaries [8] - The company develops and manufactures Class I and II medical devices, including customized and multifunctional masks, and sells disposable medical devices [8] - WORK Medical Technology has a diverse product portfolio comprising 21 products, with sales in 34 provincial-level administrative regions in China and exports to over 30 countries [8] - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, allowing entry into the U.S. market [8] Offering Details - The company closed a registered offering, selling an aggregate of 10,000,000 ordinary units at an offering price of $0.50 per unit, resulting in gross proceeds of approximately $5 million [2][4] - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [3] - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months, and both are immediately exercisable upon issuance [3] Underwriting and Regulatory Compliance - Univest Securities, LLC acted as the sole book-running manager for the offering [4] - The offering was made pursuant to a registration statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission [5]

Core Viewpoint - WORK Medical Technology Group LTD has successfully closed a registered offering of 10,000,000 ordinary units at a price of $0.50 per unit, raising a total of $5.0 million before expenses [1][3]. Summary by Sections Offering Details - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [2]. - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months [2]. - The offering was conducted on a firm commitment basis, with Univest Securities, LLC serving as the sole book-running manager [4]. Use of Proceeds - Proceeds from the offering will be allocated for upgrading production equipment, investing in research and development, hiring experienced employees for compliance improvements, and general corporate purposes [3]. Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices [6]. - The company has a diverse product portfolio of 21 products, including customized masks and medical consumables, sold in 34 regions in China and over 30 countries globally [6]. - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. FDA for market entry in the U.S. [6].

Core Viewpoint - WORK Medical Technology Group LTD has announced a strategic partnership with Shanghai Chartwell Medical Device Co., Ltd. to enhance growth and innovation in the healthcare sector [1][2]. Company Overview - WORK Medical is a supplier of Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables, sold in 34 regions in China and over 30 countries globally [3]. - Shanghai Chartwell Medical specializes in high-end medical devices and consumables, offering a wide range of products across various categories, including nuclear medicine and infection control [4]. Partnership Details - The collaboration will involve Chartwell Medical's subsidiaries, including Fuying and Fufeng, focusing on mutual growth and unlocking new opportunities [2]. - The partnership aims to enhance operational efficiency, market leadership, and international competitiveness, with a goal to advance high-end medical technologies [2]. - Specific cooperation projects are expected to enrich WORK Medical's product portfolio and increase the proportion of high-value-added products, leading to substantial revenue and profit growth over the next three years [2]. Future Initiatives - The partnership may include establishing joint investment funds, potential investment in Chartwell Medical, and co-investing in key projects related to healthcare infrastructure and advanced technology [6].